2-Chloro-5-(trifluoromethyl)pyridin-3-ol, 95.0%, 100mg

2,4-Dihydroxybenzaldéhyde, min 98 %, pour la synthèse, 250 g, emballage en verre

(Z)-2-(2-Aminothiazol-4-yl)-2-(((1-(tert-butoxy)-2-methyl-1-oxopropan-2-yl)oxy)imino)acetic acid, 95.0%, 25g

4-Chlorobenzene-1,3-diamine, 98.0%, 25g

3-Allyloxypropionic acid, 95.0%, 10g

(2,3-Dimethylbutane-2,3-diyl)dibenzene, 95.0%, 25g

6-Nitroquinoline, 98.0%, 100g

5-Bromo-2,4-dimethoxypyridine, 95.0%, 250mg

tert-Butyl 2-chloro-5H-pyrrolo[3,4-d]pyrimidine-6(7H)-carboxylate, 95.0%, 5g

tert-Butyl (4R)-4-[(E)-3-bromoprop-1-enyl]-2,2-dimethyl-oxazolidine-3-carboxylate, 97% mix TBC as stabilizer, 1g

tert-Butyl 4-(2-amino-6-fluorophenoxy)piperidine-1-carboxylate, 95.0%, 1g

Tamis de test Ø 200 mm, 4,5 mm, 1 Pièce(s)

RuCl[(R,R)-TsDPEN](mesitylene), 98%, 1g